ES2061912T3 - Un procedimiento para la preparacion de una composicion farmaceutica para la inhibicion de la formacion de metastasis de los tumores. - Google Patents

Un procedimiento para la preparacion de una composicion farmaceutica para la inhibicion de la formacion de metastasis de los tumores.

Info

Publication number
ES2061912T3
ES2061912T3 ES89123189T ES89123189T ES2061912T3 ES 2061912 T3 ES2061912 T3 ES 2061912T3 ES 89123189 T ES89123189 T ES 89123189T ES 89123189 T ES89123189 T ES 89123189T ES 2061912 T3 ES2061912 T3 ES 2061912T3
Authority
ES
Spain
Prior art keywords
inhibition
metastasis
tumors
procedure
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123189T
Other languages
English (en)
Spanish (es)
Inventor
Sai P Sunkara
Paul S Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2061912T3 publication Critical patent/ES2061912T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES89123189T 1988-12-15 1989-12-14 Un procedimiento para la preparacion de una composicion farmaceutica para la inhibicion de la formacion de metastasis de los tumores. Expired - Lifetime ES2061912T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/284,510 US4952585A (en) 1988-12-15 1988-12-15 Castanospermine esters in the inhibition of tumor metastasis

Publications (1)

Publication Number Publication Date
ES2061912T3 true ES2061912T3 (es) 1994-12-16

Family

ID=23090466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123189T Expired - Lifetime ES2061912T3 (es) 1988-12-15 1989-12-14 Un procedimiento para la preparacion de una composicion farmaceutica para la inhibicion de la formacion de metastasis de los tumores.

Country Status (12)

Country Link
US (1) US4952585A (de)
EP (1) EP0373663B1 (de)
JP (1) JP2963476B2 (de)
KR (1) KR0135278B1 (de)
AT (1) ATE96320T1 (de)
AU (1) AU621431B2 (de)
DE (1) DE68910287T2 (de)
DK (1) DK634689A (de)
ES (1) ES2061912T3 (de)
IE (1) IE62014B1 (de)
PH (1) PH26024A (de)
ZA (1) ZA899451B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4970317A (en) * 1989-08-08 1990-11-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of castanospermine esters
CA2287316C (en) * 1997-05-22 2005-02-08 Hoechst Marion Roussel, Inc. Process for preparing 6-o-monoesters of castanospermine
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
US6013459A (en) * 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
US8226684B2 (en) * 2008-12-22 2012-07-24 Ethicon, Inc. Surgical sutures having collapsible tissue anchoring protrusions and methods therefor
US8703744B2 (en) * 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
WO2017138008A2 (en) * 2016-02-14 2017-08-17 Yeda Research And Development Co. Ltd. Methods of modulating protein exocytosis and uses of same in therapy
WO2018059214A1 (zh) 2016-09-29 2018-04-05 广州君赫生物科技有限公司 影响saicar合成的化合物及应用
US11684593B2 (en) 2017-04-20 2023-06-27 Geneheal Biotechnology Co., Ltd. Applications of spermine and its derivative in preparation of antitumor drug
CA3064486C (en) 2017-04-20 2023-08-01 Geneheal Biotechnology Co., Ltd. Applications of spermidine and its derivatives
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792558A (en) * 1987-05-29 1988-12-20 Merrell Dow Pharmaceuticals Inc. Castanospermine for inhibiting tumor metastasis
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent

Also Published As

Publication number Publication date
DE68910287T2 (de) 1994-03-10
AU621431B2 (en) 1992-03-12
DK634689A (da) 1990-06-16
IE894009L (en) 1990-06-15
DK634689D0 (da) 1989-12-14
EP0373663A2 (de) 1990-06-20
AU4670789A (en) 1990-06-21
EP0373663B1 (de) 1993-10-27
JP2963476B2 (ja) 1999-10-18
EP0373663A3 (en) 1990-09-12
US4952585A (en) 1990-08-28
KR0135278B1 (ko) 1998-04-23
IE62014B1 (en) 1994-12-14
JPH02212427A (ja) 1990-08-23
PH26024A (en) 1992-01-24
KR910011256A (ko) 1991-08-07
ATE96320T1 (de) 1993-11-15
ZA899451B (en) 1990-09-26
DE68910287D1 (de) 1993-12-02

Similar Documents

Publication Publication Date Title
ES2061912T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica para la inhibicion de la formacion de metastasis de los tumores.
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
ES557835A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
ES547621A0 (es) Procedimiento para la preparacion de un medio de suministro de drogas
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
LU91173I2 (fr) Ximelagatran, et les sels pharmaceutiquement acceptables de celui-ci (exanta).
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES509163A0 (es) "un procedimiento para la preparacion de nuevos derivados de piperidina"
GR3022742T3 (en) New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
ES557816A0 (es) Un procedimiento para preparar una composicion anticariogena solida para administracion oral
AR010809A1 (es) Compuestos derivados de aminofosfonatos, un procedimiento para su preparacion, composicion farmaceutica que los comprenden, uso de los mismospara la fabricacion de un medicamento util en el tratamiento de arterioesclerosis
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
ES551390A0 (es) Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada.
ES490453A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
ES541370A0 (es) Un procedimiento para la preparacion de una composicion de etoposido en forma de dosis unitaria para administracion oral
ES551866A0 (es) Procedimiento de preparacion de nuevos derivados alquilamino-furanonas y de sales y diastereoisomeros farmaceuticamente aceptables de los mismos.
DK165168C (da) Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer
DK400887A (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
SE9000948D0 (sv) New use
IT1230612B (it) Procedimento per la preparazione di ceftriaxone e i suoi sali farmaceuticamente accettabili
IT1204952B (it) Procedimento per la preparazione di derivati alchilammino furanonici e loro sali farmaceuticamentei accettabili
ES557209A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
SE8900685D0 (sv) New compounds
DK363985A (da) Antineoplastisk middel
MX9203614A (es) Formulacion farmaceutica de liberacion controlada para administracion oral.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 373663

Country of ref document: ES